Mary J. Ortner
Director Ejecutivo en Biophagy, Inc. .
Perfil
Mary J.
Ortner is currently the President & Chief Executive Officer at Biophagy, Inc. Previously, she worked as the Chief Business Officer at SolaranRx, Inc. Dr. Ortner holds a graduate degree from California State University-Los Angeles, an MBA from the University of Connecticut, and a doctorate from the University of Hawai'i at Hilo.
Cargos activos de Mary J. Ortner
| Empresas | Cargo | Inicio |
|---|---|---|
Biophagy, Inc.
 Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner. | Director Ejecutivo | - |
Antiguos cargos conocidos de Mary J. Ortner.
| Empresas | Cargo | Fin |
|---|---|---|
SolaranRx, Inc.
 SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Corporate Officer/Principal | - |
Formación de Mary J. Ortner.
| University of Hawai'i at Hilo | Doctorate Degree |
| California State University-Los Angeles | Graduate Degree |
| University of Connecticut | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
SolaranRx, Inc.
SolaranRx, Inc. BiotechnologyHealth Technology SolaranRx, Inc. develops therapies and companion imaging agents for the treatment of metastatic melanoma. It offers radiolabeled peptide that specifically binds to melanocortin-1 receptors on the surface of melanoma cells to identify patients suitable for treatment and to deliver targeted radiation potentially destroying receptor expressing tumors. The company was founded by Les Stewart and Stuart Rose in 2014 and is headquartered in Albuquerque, NM. | Health Technology |
Biophagy, Inc.
Biophagy, Inc. Pharmaceuticals: MajorHealth Technology Biophagy, Inc. is an American biopharmaceutical company that manages standard drug development programs in several therapeutic areas. The company is also developing an OTC/DTC kit that focuses exclusively on autophagy stimulation and individual diagnostic measurement over an extended period. Biophagy's proprietary drug discovery program, CellWatch™, is being used to screen patented compounds in a variety of important disease indications to evaluate structure-activity relationships and develop leads. The company is headquartered at The BioScience Center and was founded by Stuart Rose. The CEO is Mary J. Ortner. | Health Technology |
- Bolsa de valores
- Insiders
- Mary J. Ortner
